Related Experiment Video
Updated: Jan 23, 2026

Gene Editing of Primary Rhesus Macaque B Cells
Published on: February 10, 2023
Dosing and formulation of antenatal corticosteroids for fetal lung maturation and gene expression in rhesus macaques
Augusto F Schmidt1,2,3, Paranthaman S Kannan4, James P Bridges4,5
1Division of Neonatology, Perinatal and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. aschmidt@med.miami.edu.
Insights
Low-dose antenatal corticosteroids (ANS) using betamethasone-acetate (Beta-Ac) alone effectively mature fetal lungs and reduce exposure to corticosteroids compared to the standard clinical drug.
Area of Science:
- Perinatal Medicine
- Developmental Biology
- Pharmacology
Background:
- Antenatal corticosteroids (ANS) are crucial for preventing respiratory distress syndrome in premature infants.
- Current ANS dosing regimens require optimization for efficacy and reduced fetal exposure.
- The standard clinical drug is a mixture of betamethasone-phosphate and betamethasone-acetate (Beta-Ac).
Purpose of the Study:
- To evaluate the efficacy of slow-release betamethasone-acetate (Beta-Ac) alone in promoting fetal lung maturation.
- To assess the impact of Beta-Ac on fetal corticosteroid exposure and potential toxic effects.
- To compare the effects of Beta-Ac alone versus the clinical drug on fetal gene expression.
Main Methods:
- A primate model (pregnant rhesus macaques) was used at 127 days of gestation.
- Animals were treated with either the clinical drug (0.25 mg/kg) or Beta-Ac (0.125 mg/kg).
- Lung function (compliance, surfactant concentration) and transcriptome analyses were performed.
Main Results:
- Beta-Ac alone enhanced fetal lung compliance and surfactant concentration similarly to the clinical drug.
- Transcriptome analysis showed less suppression of immune and developmental genes with Beta-Ac compared to the clinical drug.
- The clinical drug suppressed neuronal development genes in the fetal hippocampus, while Beta-Ac did not.
Conclusions:
- Low-dose antenatal corticosteroids with Beta-Ac alone is a potential alternative to the current standard treatment.
- This approach may offer equivalent lung maturation benefits with reduced fetal corticosteroid exposure and toxicity.
- Further human trials are warranted to assess the efficacy of Beta-Ac in low-dose ANS treatment.
Abstract:
Antenatal corticosteroids (ANS) are the major intervention to decrease respiratory distress syndrome and mortality from premature birth and are standard of care. The use of ANS is expanding to include new indications and gestational ages, although the recommended dosing was never optimized. The most widely used treatment is two intramuscular doses of a 1:1 mixture of betamethasone-phosphate (Beta-P) and betamethasone-acetate (Beta-Ac) - the clinical drug. We tested in a primate model the efficacy of the slow release Beta-Ac alone for enhancing fetal lung maturation and to reduce fetal corticosteroid exposure and potential toxic effects. Pregnant rhesus macaques at 127 days of gestation (80% of term) were treated with either the clinical drug (0.25 mg/kg) or Beta-Ac (0.125 mg/kg). Beta-Ac alone increased lung compliance and surfactant concentration in the fetal lung equivalently to the clinical drug. By transcriptome analyses the early suppression of genes associated with immune responses and developmental pathways were less affected by Beta-Ac than the clinical drug. Promoter and regulatory analysis prediction identified differentially expressed genes targeted by the glucocorticoid receptor in the lung. At 5 days the clinical drug suppressed genes associated with neuronal development and differentiation in the fetal hippocampus compared to control, while low dose Beta-Ac alone did not. A low dose ANS treatment with Beta-Ac should be assessed for efficacy in human trials.
More Related Videos
06:25Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining
Published on: December 23, 2016
13:13Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques
Published on: September 25, 2018
Related Concept Videos
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
What is Gene Expression?
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Cell Specific Gene Expression
Cell Specific Gene Expression
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability